ArticleTransfusion2025
An agnostic study of donor and component factors associated with transfusion-related changes in laboratory markers.
Article in Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Improved allocation strategies for red cell units of blood group O and RhD-negative revealed by current suboptimal utilization.Journal of translational medicine · 2026Article
- Redefining the role of the transfusion medicine physician in the era of advanced cellular therapies.Transfusion · 2026Review
- Fundamentals of big data and artificial intelligence in transfusion medicine.Vox sanguinis · 2026Review
- An agnostic study of donor and component factors associated with transfusion-related changes in laboratory markers.Transfusion · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDonor and red blood cell (RBC) component factors may affect patient outcomes after RBC transfusions, but data on the magnitude and consequences of these associations are limited. STUDY DESIGN AND
methodsIn this retrospective cohort study, we analyzed associations between 10 donor and component factors-including donor age, hemoglobin, parity, sex, and component storage time-and changes in 55 clinical laboratory markers measured within 24 h before and after RBC transfusions. Primary analyses used data from the Swedish SCANDAT3-S database, with findings replicated in the U.S. REDS-III database. The primary outcome was the transfusion-related change in pre- and post-transfusion values of the laboratory markers, normalized per RBC unit transfused.
resultsAfter adjusting for the false discovery rate, 33 significant associations were identified, with 20 replicated in the SCANDAT replication sample or the REDS-III cohort after Bonferroni corrections, and 18 remaining after visual assessment. Higher donor hemoglobin concentration consistently led to greater increases in recipient hemoglobin and measures of RBC mass. Extended component storage times were associated with elevated recipient bilirubin and carboxyhemoglobin levels. Differences in recipient hemoglobin response between the SCANDAT3-S and REDS-III cohorts suggest potential variations in transfusion efficacy across populations and practices. DISCUSSION: These findings suggest that considering donor hemoglobin and RBC component storage duration could enhance transfusion efficacy, providing avenues for personalized transfusion strategies to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.